Retinoblastoma protein expression is frequently altered in chronic lymphocytic leukemia.

Steven M. Kornblau(The University of Texas MD Anderson Cancer Center), A. B. Deisseroth, Susan O’Brien(University of California, Irvine), Auro del Giglio(Faculdade de Medicina do ABC), Ning Chen(Canadian Light Source (Canada))
PubMed
January 1, 1994
Cited by 46

Related Papers

Targeting BTK with Ibrutinib in Relapsed Chronic Lymphocytic Leukemia
|New England Journal of Medicine|2013|2.2k
iwCLL guidelines for diagnosis, indications for treatment, response assessment, and supportive management of CLL
|Blood|2018|1.7k
Idelalisib and Rituximab in Relapsed Chronic Lymphocytic Leukemia
|New England Journal of Medicine|2014|1.7k
Ibrutinib versus Ofatumumab in Previously Treated Chronic Lymphoid Leukemia
|New England Journal of Medicine|2014|1.6k
Safety and activity of blinatumomab for adult patients with relapsed or refractory B-precursor acute lymphoblastic leukaemia: a multicentre, single-arm, phase 2 study
|The Lancet Oncology|2014|1.3k